Precision Breast Cancer Medicine: Early Stage Triple Negative Breast Cancer—A Review of Molecular Characterisation, Therapeutic Targets and Future Trends

Precision Breast Cancer Medicine: Early Stage Triple Negative Breast Cancer—A Review of Molecular Characterisation, Therapeutic Targets and Future Trends

Personalised approaches to the management of all solid tumours are increasing rapidly, along with wider accessibility for clinicians. Advances in tumour characterisation and targeted therapies have placed triple-negative breast cancers (TNBC) at the forefront of this approach. TNBC is a highly heter...

Full description

Bibliographic Details
Main Authors: Karen Pinilla, Lynsey M. Drewett, Rebecca Lucey, Jean E. Abraham
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Oncology
Subjects:
Breast cancer
precision medicine
triple negative
therapeutic
target
biomarkers
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.866889/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.866889/full

Similar Items